GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in PsoriasisNovelty and Significance

Circulation Research - United States
doi 10.1161/circresaha.116.309637
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2014English

Cardiovascular Disease and Hair Cortisol: A Novel Biomarker of Chronic Stress

Current Cardiology Reports
Cardiovascular MedicineCardiology
2019English

Serum Α-Chlorofatty Acid as a Biomarker for Baseline Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2012English

GlycA Is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients With Type 2 Diabetes

Inflammation
AllergyImmunology
2015English

Inflammation in Cardiovascular Disease

Korean Circulation Journal
Internal MedicineCardiovascular MedicineCardiology
2017English

Distributions of Subclinical Cardiovascular Disease in a Socioeconomically and Racially Diverse Sample

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2017English

Urinary Activin a Is a Novel Biomarker Reflecting Renal Inflammation and Tubular Damage in ANCA-associated Vasculitis

PLoS ONE
Multidisciplinary
2019English

A Case of Subclinical Primary Aldosteronism and Subclinical Cushing's Syndrome Without Risk Factors of Cardiovascular Disease

Endocrine Abstracts
2016English

Adipose Tissue, Inflammation and Cardiovascular Disease

Revista da Associacao Medica Brasileira
Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy